• 06 Mar, 2025

Cure© Hosts Power of X Summit to Drive Investment and Solutions in Untapped Trillion-Dollar Market Addressing Health of Women

Cure© Hosts Power of X Summit to Drive Investment and Solutions in Untapped Trillion-Dollar Market Addressing Health of Women

Event's Impact Challenge to Award One Early-Stage Company Up to $100K for Innovative Women's Health Solutions

NEW YORK, March 6, 2025 -- Cure, a premier healthcare innovation ecosystem headquartered in New York City, is set to host the Power of X Summit: Solutions for an Untapped Market, March 24 to 25, 2025, at Cure's conference center located at 345 Park Avenue South. The flagship, in-person event will bring together thought leaders sharing insights and resources to help healthcare innovators build their investment case and business strategies to progress their solutions for the health of women from ideas to the marketplace.

"Cure's mission is to accelerate cures by providing expert insights, resources and mentoring to help healthcare innovators develop their groundbreaking products and services from concept to commercialization," said Seema Kumar, CEO of Cure. "Our goal is to be a go-to hub for entrepreneurs across the healthcare spectrum. The Power of X Summit and Impact Challenge are powerful examples of how Cure lives into our mission."

KPMG is a lead sponsor of the Summit. Cure is hosting the Power of X Summit in collaboration with Cancer Vaccine Coalition, CIF, and Women's Health Access Matters (WHAM).

The Impact Challenge at the Power of X Summit, is a competition that will award an equity investment prize to one startup or early-stage company ranging from $50,000 to $100,000 to support innovative projects that target significant societal needs for the health of women. The Catalytic Impact Foundation (CIF) and Orrick, Herrington & Sutcliffe sponsor the competition, which will also award $10,000 of in-kind legal services.

The Power of X Summit agenda is designed to raise awareness and encourage investment in the health of women, a market that could boost global economies by $1 trillion by 2040. Every dollar invested in this market is projected to lead to triple its value in economic growth. Just 2.3 percent of the $49.95 billion in venture funding for health or healthcare in 2024 went to the women's health companies. Cure addressed the market in its December 2024 benchmark report, Unlocking the Opportunity: What's Needed to Innovate, Invest and Impact the Health of Women

Power of X Summit Offers Opportunity to Connect with Industry Trailblazers

The conference offers opportunities to hear from and network with a diverse array of more than 40 speakers, ranging from healthcare CEOs and investors to R&D leaders and public health experts to media personalities. They will discuss healthcare trends, the investment landscape, new business models, research and product development activities, regulatory and compliance engagement, and business development planning.

Kumar will open the Power of X Summit with a welcome and State of the Industry remarks. Carolee Lee, Founder and Chief Executive Officer of WHAM, will then discuss "The WHAM Report: The Business Case for Accelerating Women's Health Investment."

The Power of X Summit will also feature a Fireside Chat on March 24 with Margaret Hamburg, MD, President and Co-Chair, InterAcademy Partnership and former Commissioner of the U.S. Food and Drug Administration.

The conference includes panel discussions on innovative technology and therapies, care delivery, healthcare coverage and services. Sessions will also address key therapeutic areas impacting women only, differently or disproportionately including Alzheimer's disease, autoimmune conditions, brain health, breast cancer, cardiovascular disease and menopause, as well as  healthcare challenges for women of color.

Among experts from the financial sector planning to speak at the Power of X Summit will be: Katherine Andersen, Head of U.S. Life Science & Healthcare, HSBC Innovation Banking; Rachel Butler, President, Catalytic Impact Fund; Scott Donohue, Senior Director, Market Access, Deerfield Management; Howard Levin, MD, Chief Executive Officer and Chief Medical Officer, Deerfield Catalyst; Richard Lipkin, Founder & Co-Chair, Catalytic Impact Foundation; Viq Pervaaz, Senior Vice President of Life Sciences & Healthcare, New York City Economic Development Corporation; Stacey Seltzer, Managing Partner and Founder, Pontiva Healthcare Partners and Cameron Wheeler, PhD, Partner, Deerfield Management.

Impact Challenge to Award Up to $100K for Innovative Women's Health Solutions
The Impact Challenge, supported by CIF, will award between $50,000 and $100,000 in equity investment funding to one startup or early-stage company working to develop scalable, high-impact innovative solutions designed to address diseases or conditions predominantly, differently, or exclusively affecting women.

In addition, winners will receive legal counsel valued up to $10,000 from Orrick, Herrington & Sutcliffe and strategic mentorship and access to Cure's extensive network of industry leaders and investors.

Finalists, selected March 6 from more than 100 applicants, will receive coaching for live pitching sessions to take place during the Summit on March 25 to a panel of expert judges.

Agenda and Registration

The full Power of X Summit  agenda, speakers list, Impact Challenge information and registration are available at the Power of X Summit. Registration for the Power of X Summit is required. Qualified Investors receive complimentary registration.

About Cure.®
Cure is a premier healthcare innovation ecosystem headquartered in New York City, with a mission to accelerate cures by helping health innovators develop their groundbreaking products and services from concept to commercialization. Cure's thriving NYC campus includes state-of-the-art research and business facilities, and its digital ecosystem serves as the go-to resource for health innovators. Its dedicated content hub offers expert-driven insights, resources, mentoring, networking, and business services. The on-campus Cure Collaboration Residency companies include startups and established enterprises. Cure also hosts and convenes flagship events and conferences, bringing together thought leaders from across sectors in its premium venues, including an education center, conference center, and iconic rooftop. For more information, please visit wewillcure.com.

This News is brought to you by Qube Mark, your trusted source for the latest updates and insights in marketing technology. Stay tuned for more groundbreaking innovations in the world of technology. 

PR Newswire

PR Newswire empowers communicators to identify and engage with key influencers, craft and distribute meaningful stories, and measure the financial impact of their efforts. Cision is a leading global provider of earned media software and services to public relations and marketing communications professionals.